Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882 as Potential New Therapeutic Approach for Diffuse Large B-Cell Lymphoma

Source :: Business Wire. December 9, 2023
Publication Year :: 2023
Abstract: SC-2882 shows anti-lymphoma and anti-immunosuppression effect in a mouse model for diffuse large B-Cell lymphoma Data presented today, December 9, at the 65th ASH Annual Meeting & Exposition in San [...]

Subjects :: Biotechnology -- Analysis -- Health aspects
Non-Hodgkin's lymphomas -- Analysis -- Health aspects
Immunotherapy -- Analysis -- Health aspects
College teachers -- Health aspects -- Analysis
Business
Business, international

Tools